IRCT20170112031893N3
Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient
Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient, a triple-blind randomized, placebo controlled trial
Ghoum University of Medical Sciences·Phase 3·Iranian Registry Of Clinical Trial·biologicalCompleted
Study focus
- Disease/Condition
- Non-insulin-dependent diabetes mellitus
- Study type
- Interventional
- Intervention type
- biological
Sponsor & location
- Primary sponsor
- Ghoum University of Medical Sciences
- Funder
- Qom University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Jan 21, 2019
- End date
- N/A
ICD-10 classifications
Other specified diabetes mellitus without complicationsUnspecified diabetes mellitus without complicationsOther specified diabetes mellitusOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20170112031893N3
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20170112031893N3 through Pure Global AI's free database. This Phase 3 trial is sponsored by Ghoum University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.